DPP-IV/CD26 has been closely related to the oncogenic process as a marker of malignancy in colorectal cancer, pleural mesothelioma, hepatocellular carcinoma, and hematologic disorders, with potential implication on stemness pathways [28,29,30,31,32,33]. This evidence concerns the gene DPP4 and colorectal cancer.